Trial Profile

A Phase 3 clinical trial evaluating TOUR006 in cardiovascular disease.

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 23 May 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

19 May 2025 According to the Tourmaline Bio media release, expects to provide further information on a potential Phase 3 cardiovascular outcomes trial in ASCVD later in 2025 following discussions with regulatory authorities.
17 May 2024 New trial record
16 May 2024 According to the Tourmaline Bio media release, the results from the Phase 2 TRANQUILITY trial are expected to position Tourmaline to be Phase 3 ready in 2025 for ASCVD and other cardiovascular diseases.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com